Test Price
2,800 AED✅ Home Collection Available
RPS29 Gene Diamond-Blackfan Anemia Type 13 Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
Clinical Confidence, Delivered at Your Doorstep.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Sequencing (Illumina platform, validated pipeline).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection — Available daily from 8 AM to 11 PM, 7 days a week.
- Clinical Guidance: Complimentary telephonic post-test genetic counselling for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- DHA Licensed Facility: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — License No. 1143.
Test Overview & Methodology
This Next‑Generation Sequencing (NGS) test comprehensively analyses the RPS29 gene to detect pathogenic variants causing Diamond‑Blackfan anemia type 13, a congenital pure red cell aplasia. Designed for families, hematologists, and clinical geneticists, it delivers unmatched variant‑level resolution with a 3‑4 week turnaround. The methodology includes full gene coverage with copy number variant (CNV) detection, exceeding the diagnostic yield of traditional Sanger sequencing.
Sample collection is performed via VIP Mobile Phlebotomy at your home or an accredited DNA Labs UAE draw centre. Sample types accepted: Whole Blood (EDTA tube), Extracted DNA (≥1 µg), or FTA Card. A mandatory 30-minute pre-test genetic counselling session is included to document pedigree and clinical history as required by UAE law.
| Feature | Our RPS29 NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Massively Parallel NGS (full gene, CNV detection) | Targeted capillary sequencing (point mutations only) |
| Diagnostic Sensitivity | >99.9% (including large deletions/duplications) | ~95% (misses structural variants) |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| UAE-DHA Approved | Yes | Limited Labs |
Physician Insight & Safety Protocols
“In my practice, a genetic diagnosis is never a standalone conclusion. We integrate RPS29 variant findings with complete blood counts, bone marrow cytology, and a three-generation family pedigree to construct a personalised care plan for every patient. I guide each family through this journey with clinical precision and compassionate communication.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication Safety & Clinical Supervision
Important Clinical Advisory
Do not discontinue prescribed corticosteroid therapy, immunosuppressive agents, or any hematological medication without explicit instruction from your supervising physician. Abrupt cessation can precipitate aplastic crisis, severe anemia, or life-threatening complications. Always consult your specialist before making any changes to your treatment regimen.
Patient Exclusion Criteria & Emergency Red Flags
Exclusion Criteria & Sample Rejection Guidelines
- Exclusion for home collection: Active febrile illness, oozing from puncture site, hematoma propensity, or known bleeding disorder.
- Sample rejection: Clotted or hemolyzed whole blood, insufficient DNA (<1 µg), sample older than 72 hours without proper cold-chain documentation.
- Emergency red flags — seek immediate care: Sudden severe pallor, dyspnea at rest, signs of congestive heart failure, altered consciousness, or rapid drop in hemoglobin. These may indicate acute red cell aplasia requiring urgent transfusion support.
Patient FAQ & Clinical Guidance
1. What is the RPS29 gene Diamond-Blackfan anemia type 13 genetic test?
The RPS29 gene NGS test accurately detects pathogenic mutations linked to Diamond-Blackfan anemia type 13 with 99.9% diagnostic sensitivity, enabling early intervention, transfusion planning, and cascade family screening. It analyses the entire coding region and splice sites for point mutations, small insertions/deletions, and large copy number variants.
2. Why is genetic counselling required before this test in the UAE?
Pre-test genetic counselling ensures proper pedigree analysis, informed consent, and compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability and Federal Law No. 2 of 2019 concerning health ICT. This safeguards your family’s rights, confirms the appropriateness of testing, and optimises clinical accuracy.
3. How accurate is the Diamond-Blackfan anemia type 13 NGS panel compared to older methods?
Next-generation sequencing surpasses Sanger sequencing by analysing the entire RPS29 gene region, reducing false negatives to near zero and capturing even large deletions or duplications. This comprehensive coverage provides a diagnostic sensitivity exceeding 99.9%, compared to approximately 95% for traditional capillary sequencing.
4. What sample types are accepted and how is home collection arranged?
We accept Whole Blood (EDTA tube), Extracted DNA (≥1 µg), or FTA Card samples. Our DHA-licensed phlebotomists perform VIP Mobile Phlebotomy at your home between 8 AM and 11 PM daily, including weekends and public holidays. All samples are transported under temperature-controlled cold-chain conditions to our ISO-accredited laboratory.
UAE Regulatory & Data Privacy Adherence
Data Protection & Health Information Governance
This genetic test strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All DNA samples are processed in-country under ISO 9001:2015 certified infrastructure. Your genomic data remains within UAE jurisdiction and is never transferred abroad. Clinical safety and patient consent protocols comply with Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE holds DHA Facility License No. 1143 and operates from Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | RPS29 Gene Diamond-Blackfan Anemia Type 13 Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks from sample receipt |
| Sample Type / Matrix | Whole Blood (EDTA tube), Extracted DNA (≥1 µg), or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) with full gene coverage and CNV detection |
| ICD-10-CM Code | D61.01 (Constitutional pure red cell aplasia) |
| LOINC Code | 82337-8 (Genetic counseling and testing for inherited hematologic disorder) |
| DHA Facility License & Laboratory Address | License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians